Skip to main content

Heparin-bonded ePTFE grafts compared with vein grafts in femoropopliteal and femorocrural bypasses: 1- and 2-year results

K. Daenens, et al., 20091

University Hospital Gasthuisberg, Belgium

Primary patency of GORE® PROPATEN® Vascular Graft

N=86
1 year 92%
2 years 83%

Patient characteristics*

Characteristic N %
Rutherford classification  
3 63 26%
4 60 25%
5 84 35%
6 17 7%
Smokers 149 62%
Redo bypass 86 36%

Study details

  • Retrospective, non-randomized, single-center study
  • Study compared results from GORE® PROPATEN® Vascular Graft to autologous vein bypasses
  • The 1 and 2 year primary patency rates for above-knee fem-pop bypasses using autologous vein were 91% and 80%, respectively

Overall, our results...provide solid additional evidence that heparin-bonded ePTFE grafts represent an important new option in the treatment of peripheral arterial disease. – K. Daenens


*GORE® PROPATEN® Vascular Graft group, N = 240

1. Daenens K, Schepers S, Fourneau I, Houthoofd S, Nevelsteen A.  Heparin-bonded ePTFE grafts compared with vein grafts in femoropopliteal and femorocrural bypasses: 1- and 2-year results.  Journal of Vascular Surgery 2009;49(5):1210-1216.